MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q2 2020. The put-call ratio across all filers is 1.56 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $930,000 | +353.7% | 51,847 | +469.7% | 0.01% | +300.0% |
Q3 2021 | $205,000 | -62.0% | 9,100 | -65.3% | 0.00% | -71.4% |
Q2 2020 | $540,000 | -41.9% | 26,200 | -56.3% | 0.01% | -69.6% |
Q4 2019 | $930,000 | +681.5% | 59,900 | +162.7% | 0.02% | +666.7% |
Q3 2019 | $119,000 | -88.5% | 22,800 | -65.9% | 0.00% | -96.8% |
Q3 2017 | $1,035,000 | +26.4% | 66,900 | -4.4% | 0.10% | +13.1% |
Q2 2017 | $819,000 | -0.4% | 70,000 | 0.0% | 0.08% | +2.4% |
Q1 2017 | $822,000 | -5.6% | 70,000 | 0.0% | 0.08% | -27.4% |
Q4 2016 | $871,000 | – | 70,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
VitalStone Financial, LLC | 15 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |